• 中国科学论文统计源期刊
  • 中国科技核心期刊
  • 美国化学文摘(CA)来源期刊
  • 日本科学技术振兴机构数据库(JST)

JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE ›› 2026, Vol. 28 ›› Issue (2): 161-167.DOI: 10.3969/j.issn.1671-2587.2026.02.002

Previous Articles     Next Articles

RhCE Antigens Matching for Transfusion Patients in China — Chinese Expert Consensus

The Consensus Drafting Group on RhCE Antigens Matching for Transfusion Patients in China — Chinese Expert Consensus   

  • Received:2026-01-23 Accepted:2026-02-03 Online:2026-04-20 Published:2026-04-22

Abstract: The distribution of RhCE antigens in the Chinese populations differs from that in Caucasians and Africans, and genetic differences are also observed between northern and southern Chinese. The probability of RhCE antigen mismatch (23.6% to 26.31%) in Chinese transfusion patients is significantly higher than that of RhD antigen mismatch (0.39% to 0.45%), leading to a high incidence of RhCE alloantibodies in transfusion-related cases. Clinical transfusion studies indicate that RhCE antigen matching can reduce the risk of alloimmunization. This consensus proposes a RhCE antigen matching strategy for Chinese transfusion patients based on Landsteiner's rule and the distribution characteristics of RhCE antigens in the Chinese population.

Key words: Rh blood group, RhCE antigen matching, Blood transfusion, Expert

CLC Number: